Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke)
NCT ID: NCT02607358
Last Updated: 2016-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
496 participants
OBSERVATIONAL
2015-01-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
NCT06638151
Clopidogrel for Acute Ischaemia of Recent Onset
NCT02776540
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients with Acute Ischemic STROKE
NCT06853535
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clopidogrel
Clopidogrel non-responders (HOTPR) Blood sampling for HOTPR-testing
blood sampling for HOTPR-testing
All subjects are tested for responderstatus using the VerifyNow System
Acetacylicacid
Acetcylicacid non-responders (HOTPR), Blood sampling for HOTPR-testing
blood sampling for HOTPR-testing
All subjects are tested for responderstatus using the VerifyNow System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sampling for HOTPR-testing
All subjects are tested for responderstatus using the VerifyNow System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* NOAC or Vitamin K-antagonist treatment
* Final diagnosis other than Ischemoc stroke or Transitoric ischemic attack
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charlotte Rath, MD
Role: PRINCIPAL_INVESTIGATOR
Zealand University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neurologisk afdeling
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJ-390
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.